EC
CMTA

EcoR1 Capital’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

EcoR1 Capital’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-194,166
Closed -$3.69M – 41
2017
Q4 		$3.69M Hold
194,166
– – 0.41% 25
2017
Q3 		$3.28M Buy
+194,166
New +$3.17M 0.44% 29

Other funds holding CMTA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

EcoR1 Capital's CMTA Position: Q1 2018 in Review

EcoR1 Capital sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q1 2018, closing a stake of 194,166 shares — an estimated $3.69M sold.

EcoR1 Capital first reported a position in CMTA in Q3 2017 and held it in 2 quarters. The position peaked at $3.69M in Q4 2017. 38 funds tracked by Wall St. Rank hold CMTA as of Q1 2018.

  • EcoR1 Capital reported no remaining Clementia Pharmaceuticals Inc. position as of Q1 2018 after selling out during the quarter.
  • EcoR1 Capital sold 194,166 Clementia Pharmaceuticals Inc. shares in Q1 2018, an estimated $3.69M.
  • EcoR1 Capital first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 2 quarters.
  • EcoR1 Capital's Clementia Pharmaceuticals Inc. position peaked at $3.69M in Q4 2017.
  • 38 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q1 2018.

Based on EcoR1 Capital's 13F filing for Q1 2018, filed 15 May 2018.